BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22407312)

  • 21. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
    Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
    Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma.
    Liu Q; Chen J; Wang J; Amos C; Killary AM; Sen S; Wei C; Frazier ML
    Mol Carcinog; 2014 Sep; 53(9):711-21. PubMed ID: 23661430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentially expressed microRNAs in pancreatic cancer stem cells.
    Jung DE; Wen J; Oh T; Song SY
    Pancreas; 2011 Nov; 40(8):1180-7. PubMed ID: 21785383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
    Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
    Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.
    Ohuchida K; Mizumoto K; Ishikawa N; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2005 Nov; 11(21):7785-93. PubMed ID: 16278400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
    Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH
    Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a metastatic fluorescent Lewis Lung carcinoma mouse model: identification of mRNAs and microRNAs involved in tumor invasion.
    Rask L; Fregil M; Høgdall E; Mitchelmore C; Eriksen J
    Gene; 2013 Mar; 517(1):72-81. PubMed ID: 23296057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
    Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
    Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer.
    Hiroshima Y; Nakamura F; Miyamoto H; Mori R; Taniguchi K; Matsuyama R; Akiyama H; Tanaka K; Ichikawa Y; Kato S; Kobayashi N; Kubota K; Nagashima Y; Goshima Y; Endo I
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S369-78. PubMed ID: 22805864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
    Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.
    Yabushita S; Fukamachi K; Tanaka H; Sumida K; Deguchi Y; Sukata T; Kawamura S; Uwagawa S; Suzui M; Tsuda H
    Pancreas; 2012 Oct; 41(7):1013-8. PubMed ID: 22513294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.
    Guweidhi A; Kleeff J; Giese N; El Fitori J; Ketterer K; Giese T; Büchler MW; Korc M; Friess H
    Carcinogenesis; 2004 Sep; 25(9):1575-85. PubMed ID: 15073049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer.
    Koide N; Yamada T; Shibata R; Mori T; Fukuma M; Yamazaki K; Aiura K; Shimazu M; Hirohashi S; Nimura Y; Sakamoto M
    Clin Cancer Res; 2006 Apr; 12(8):2419-26. PubMed ID: 16638847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
    Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
    Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of microRNAs in patients with pancreatic cancer and its prognostic significance.
    Papaconstantinou IG; Manta A; Gazouli M; Lyberopoulou A; Lykoudis PM; Polymeneas G; Voros D
    Pancreas; 2013 Jan; 42(1):67-71. PubMed ID: 22850622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration.
    Xu L; Li Q; Xu D; Wang Q; An Y; Du Q; Zhang J; Zhu Y; Miao Y
    Int J Oncol; 2014 Feb; 44(2):459-66. PubMed ID: 24285464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
    Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
    Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
    Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE
    Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.